Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Advances in Therapy
|
June 10, 2005
Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study
W Milano, C Petrella, A Casella, et al.
Peptides
|
August 23, 2005
The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions
M Broccardo, G Linari, R Guerrini, et al.
Biochemistry
|
December 24, 1996
Structural requirements and thermodynamics of the interaction of proline peptides with profilin
E C Petrella, L M Machesky, D A Kaiser, et al.
Analytical Biochemistry
|
April 10, 1995
Phospholipid/alkanethiol bilayers for cell-surface receptor studies by surface plasmon resonance
A L Plant, M Brigham-Burke, E C Petrella, et al.
Immunobiology
|
December 31, 1997
Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells
H Juhl, E C Petrella, N K Cheung, et al.
Molecular Immunology
|
October 1, 1990
Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic
H Juhl, E C Petrella, N K Cheung, et al.
Neurogastroenterology and Motility
|
December 13, 2005
Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors
M Broccardo, S Scaccianoce, P Del Bianco, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1992
Primary structure of cobra complement component C3
D C Fritzinger, E C Petrella, M B Connelly, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1994
Immunoreactivity and function of oligosaccharides in cobra venom factor
D C Gowda, E C Petrella, T T Raj, et al.
Cancer Research
|
February 1, 1993
Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65
M W Ollert, J V Kadlec, E C Petrella, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Advances in Therapy
|
June 10, 2005
Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study
W Milano, C Petrella, A Casella, et al.
Peptides
|
August 23, 2005
The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions
M Broccardo, G Linari, R Guerrini, et al.
Biochemistry
|
December 24, 1996
Structural requirements and thermodynamics of the interaction of proline peptides with profilin
E C Petrella, L M Machesky, D A Kaiser, et al.
Analytical Biochemistry
|
April 10, 1995
Phospholipid/alkanethiol bilayers for cell-surface receptor studies by surface plasmon resonance
A L Plant, M Brigham-Burke, E C Petrella, et al.
Immunobiology
|
December 31, 1997
Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells
H Juhl, E C Petrella, N K Cheung, et al.
Molecular Immunology
|
October 1, 1990
Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic
H Juhl, E C Petrella, N K Cheung, et al.
Neurogastroenterology and Motility
|
December 13, 2005
Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors
M Broccardo, S Scaccianoce, P Del Bianco, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1992
Primary structure of cobra complement component C3
D C Fritzinger, E C Petrella, M B Connelly, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1994
Immunoreactivity and function of oligosaccharides in cobra venom factor
D C Gowda, E C Petrella, T T Raj, et al.
Cancer Research
|
February 1, 1993
Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65
M W Ollert, J V Kadlec, E C Petrella, et al.
Page
of 5